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The increasing rise and impact of HPB
I apologise to Mark Callery for displacing him to an editorial that highlights the excellent research 
article by Nagano and colleagues but 2012 is proving a watershed for HPB. Having secured its fi rst 
impact factor last year, the Journal continues to climb the category rankings within the top 100 
journals in Surgery (78/198) achieving an increased impact factor of 1.604. Furthermore, almost 
250 manuscripts had been submitted for consideration of publication by the end of June, easily 
exceeding the entire submission total for 2010. HPB’s visibility and profi le rise relentlessly and have 
complemented the recent success of the IHPBA World Congress in Paris in July. The support that 
HPB and its editors has received from the editorial board and its reviewers has been outstanding 
and all those who have submitted manuscripts and been involved in the review process should be 
congratulated on their striving to further increase the quality of the Journal.
James Garden
HCC resect or transplant – what would you do?
The best mode of treating hepatocellular carcinoma remains a hot topic of debate. While studies 
consistently show improved long term survivals from transplantation there is a signifi cant risk in 
many countries of having to wait a very long time for a transplant. Coupled with concern over 
waiting and tumour growth is the issue of the increased early operative mortality associated with 
liver transplantation. In this issue of HPB, Dhir and colleagues from the University of Nebraska 
Medical Centre, present a meta-analysis addressing the question of whether outcome is superior 
with liver transplantation or resection for HCC. They found evidence of survival benefi t for trans-
planted patients looking at all randomized studies with an odds ratio of 0.53. Interestingly, however, 
this survival benefi t disappeared when only studies using an intention to treat comparison were 
included. This implies that a number of patients who were waiting for liver transplantation devel-
oped advanced disease and died waiting for a transplant. Resection has been used as a defi nitive 
treatment and as a bridge to transplantation. Transplantation has been used as a defi nitive treat-
ment or as a salvage procedure for those with new or recurrent HCC after resection. The correct 
strategy depends partly on local supply and demand of livers for transplantation but also on the 
underlying disease. There is some evidence that salvage transplantation in patients with hepatitis 
C virus cirrhosis may be very risky for multifocal recurrence and ineligibility for transplantation. 
Picking the right strategy for the individual patient remains a real challenge.
Stephen J Wigmore
Alternatives to epidural analgesia for patients undergoing 
hepatic resection
Epidural analgesia is often promoted as a cornerstone to the successful implementation of enhanced 
recovery programmes for patients undergoing major abdominal surgery. The potential advantages 
include superior pain relief and reduction in complications. There is, however, increasing evidence 
that in the ‘real world’ outside of clinical trials that these outcomes are not being achieved. Reasons 
include lack of resources to appropriately manage epidurals and high failure rates. In this issue of 
HPB, Revie et al. report a well conducted randomised controlled trial comparing epidural analgesia 
to continuous wound catheters combined with intravenous opiates for patients undergoing hepatic 
resection. Sixty fi ve patients were randomised. The important fi nding was the reduction in median 
length of hospital stay in those who had wound catheters alone to 4.5 days as compared to 6 days 
for those in the epidural group. Although those in the epidural group reported lower pain scores 
at rest and on movement indicating superior analgesia in that group, the overall pain score was 
mild in both groups raising the question of clinical signifi cance. What was also noteworthy was 
that there was no difference in mobility in the two groups for the fi rst 48 hours but it should be 
highlighted that overall mobility in both groups was poor. For those surgeons still using epidurals 
for patients undergoing hepatic resection this paper is well worth reading in detail as it is highly 
likely to lead to a change in practice.
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